Yatsen Announces Fourth Quarter and Full Year 2021 Financial Results
China Zhongshan Holdings Limited (“Yat-sen” or “the Company”), a leading beauty company in China (NYSE: YSG), today announced its unaudited… Read More »
Infosys Becomes Digital Innovation Partner for International Tennis Hall of Fame and Title Sponsor of the Hall of Fame Open
Strategic collaboration to bring technology expertise to reimagine fan experiences and preserve tennis heritage at the historic venue where the… Read More »
Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial
Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Venatorx Pharmaceuticals, reported positive results from its pivotal Phase 3… Read More »
Pulnovo Medical Appoints Ms. Jessie Lian Jia as New CEO
Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Ms. Jessie Lian Jia as Chief… Read More »
Beijing 2022 Paralympics Winter Games: Equality and Respect makes Accessibility
A news report from China.org.cn on China’s parasports development: At the National Biathlon Center in Zhangjiakou, a special lane of… Read More »
Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for February 2022
Senmiao Technology Limited (“Senmiao” or the “Company”) (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry… Read More »
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022
Gracell to present first-in-human data on GC502, an allogeneic CD19/CD7 dual-directed chimeric antigen receptor (CAR) T cell therapy Gracell Biotechnologies… Read More »
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer
ProfoundBio announced that preclinical data from its pipeline of novel, proprietary antibody-drug conjugates (ADCs) and technology will be presented at… Read More »
BEST Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2021 Financial Results
BEST Inc. (NYSE: BEST) (“BEST” or the “Company”), a leading integrated smart supply chain solutions and logistics services provider in China,… Read More »
Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related… Read More »